Selected article for: "antigen delivery and immune cell"

Author: Chattopadhyay, Saborni; Chen, Jui-Yi; Chen, Hui-Wen; Hu, Che-Ming Jack
Title: Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation
  • Document date: 2017_6_9
  • ID: 7q2wkwrf_26
    Snippet: Semiconductor quantum dots have been applied for vaccine applications, offering a versatile platform for nanoparticulates antigen delivery with the added benefit of particle tracking. In a study by Cambi et al., antigen-conjugated quantum dots of virus-like dimension were shown to combine antigen delivery and bioimaging functionalities, enabling immune cell tracking following antigen uptake. It presented the possibility of tracking antigen-presen.....
    Document: Semiconductor quantum dots have been applied for vaccine applications, offering a versatile platform for nanoparticulates antigen delivery with the added benefit of particle tracking. In a study by Cambi et al., antigen-conjugated quantum dots of virus-like dimension were shown to combine antigen delivery and bioimaging functionalities, enabling immune cell tracking following antigen uptake. It presented the possibility of tracking antigen-presenting cells in vivo [126] . Along similar lines, Sen et al. showed that quantum dots can induce T cell proliferation and IFN-γ production in vivo while being traceable within lymph nodes [127] . Other nanoparticle platforms with imaging functionality, including polymeric upconversion nanoparticles [128] , and iron oxide nanoparticles [129] , have also been studied as antigen carriers for vaccine applications. These platforms offer the capability for examining the function mechanisms behind the benefits of nanoparticle vaccines.

    Search related documents:
    Co phrase search for related documents
    • antigen carrier and nanoparticle vaccine: 1
    • antigen carrier and vaccine application: 1, 2
    • antigen conjugate and lymph node: 1
    • antigen conjugate and nanoparticle vaccine: 1
    • antigen delivery and cell proliferation: 1
    • antigen delivery and IFN γ production: 1
    • antigen delivery and lymph node: 1, 2, 3, 4, 5
    • antigen delivery and nanoparticle platform: 1
    • antigen delivery and nanoparticle vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antigen delivery and vaccine application: 1, 2, 3, 4, 5
    • antigen present and cell proliferation: 1
    • antigen present and IFN γ production: 1, 2
    • antigen present and lymph node: 1, 2, 3, 4, 5, 6
    • antigen present and nanoparticle platform: 1
    • antigen present and nanoparticle vaccine: 1
    • antigen present and nanoparticle vaccine benefit: 1
    • antigen present and vaccine application: 1, 2